PRMT5 activity possesses myeloproliferative effects that stem from its interaction with receptor tyrosine kinase FLT3, a protein often mutated in acute myeloid leukemia (AML) [91]. This evidence concerns the gene PRMT5 and acute myeloid leukemia.